{
  "id": 14343478,
  "title": "PharmX Q1 FY27 slides: marketplace GTV surges 150%, targets $100m run-rate",
  "url": "https://urgent.news/2026/10/14/pharmx-q1-fy27-slides-marketplace-gtv-surges-150-targets-100m-run-rate",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-14T01:52:09.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/pharmx-q1-fy27-slides-marketplace-gtv-surges-150-targets-100m-runrate-93CH-4947867"
  },
  "original_language": "en",
  "account": "PharmX Technologies Limited (ASX:PHX) reported its Q1 fiscal 2027 results on October 14, 2026. Revenue grew 9% year-over-year, with recurring revenue shifting towards volume-based fees. Marketplace gross transaction value (GTV) surged 150% to A$6.9 million, representing 45% growth compared to the prior month. The platform aimed to reach A$100 million in annualized run-rate by March 2027. User engagement metrics improved, with monthly purchase frequency rising 39% and total monthly spend per pharmacy up 122%. The company's strategic alliance with Sigma Healthcare marked a significant milestone, with Relay EDI solution launched at Sigma's South Auckland distribution center. Relay EDI handled purchase orders, advanced shipping notices, and invoices, integrating with 12 customers, with 10 implementations completed and 40 more in pipeline. PharmX's serviceable GTV opportunity across its EDI platforms totaled more than A$20 billion.",
  "summary": null,
  "key_points": [
    "Q1 FY27 revenue grew 9% year-over-year",
    "Marketplace GTV surged 150% to A$6.9 million",
    "Platform targets A$100 million annualized run-rate by March 2027"
  ],
  "editors_take": "The rapid acceleration of marketplace transaction value and deeper integration with Sigma Healthcare signals a fundamental shift toward a high-volume, recurring revenue model for the platform.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}